HTB news: review of 2024, new pipeline research, IAS-USA guidelines…

1 January 2025. Related: News.

LATEST NEWS

• Looking back through 2024 and forward to 2025…

This review of the last year highlights key themes that will be just as important in 2025: LGBT+ rights, the HIV pipeline, advances in PrEP, lenacapavir access, GLP-1 agonists, mpox, guidelines and special reports.

• ART pipeline 2025: exciting dual long-acting combinations and the challenge of generic dolutegravir

Comprehensive review on the HIV pipeline for 2025 by José Arribas in Glasgow. From weekly oral ART to six-monthly injectable combinations.

• IAS-USA 2024 guidelines for HIV treatment and prevention: some differences to EACS and UK

Short review of these new US guidelines that include information about weight changes and support some easier dosing options for PrEP.

• Lenacapavir submitted to the US FDA with an indication for HIV PrEP

ALL REPORTS

• January 2025
• December 2024
• November reports

All back issues

Please subscribe to receive a free email every 3-4 weeks of the latest news.

• Subscribe to HTB by email

Reports will also be posted to social media at the same time.

Twitter (x)        Facebook        Instagram